News
Nova Minerals Limited ("Nova" or the "Company") (NASDAQ: NVA) (ASX: NVA) (FRA: QM3)) is pleased to announce that preparations ...
Valvoline Global is set to make its partnership debut with FIFA's flagship tournament.The sponsorship reflects the rapid ...
KELOWNA, BC / ACCESS Newswire / May 30, 2025 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading producer of innovative and award-winning cannabis products, hel ...
Zedcor Inc. (TSXV: ZDC) (the "Company" or "Zedcor") announces that on May 29, 2025, 2,935,000 Restricted Share Units (RSUs) were granted to employees ...
VANCOUVER, BC / ACCESS Newswire / May 30, 2025 / Banyan Gold Corp. (the "Company" or "Banyan") (TSXV:BYN)(OTCQB:BYAGF) announces today that, as a result of a review by staff of the British Columbia Se ...
ANAHEIM, CA / ACCESS Newswire / May 30, 2025 / Phoenix Motor Inc. (OTC PINK:PEVM), a leading manufacturer of heavy-duty transit buses and electrification solutions provider for medium-duty vehicles, t ...
Very Polite Agency is pleased to announce it is a Gold Sponsor at the Centurion One Capital 6th Annual LA Summit held at the iconic Beverly ...
VANCOUVER, BC / ACCESS Newswire / May 30, 2025 / GLG Life Tech Corporation (TSX:GLG) ("GLG" or the "Company"), a global leader in the agricultural and commercial development of high-quality zero-calor ...
VANCOUVER, BC / ACCESS Newswire / May 30, 2025 / Metavista3D Inc. (TSXV:DDD)(FSE:E3T) ("Metavista3D" or the "Company") is providing this bi-weekly default status report in accordance with National Pol ...
SAN ANTONIO, TEXAS / ACCESS Newswire / May 30, 2025 / To keep the spotlight on women in global aviation and aerospace in recent months, Olga Custodio's release of her awe-inspiring memoir, Flightpath ...
PALO ALTO, CA / ACCESS Newswire / May 30, 2025 / Riboscience, LLC, today announced the presentation of data from the completed dose escalation Phase 1a of the Phase 1a/b clinical trial of the ENPP1 in ...
TURKU, FI / ACCESS Newswire / May 30, 2025 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN) - Phase I study shows promising clinical activity and tolerability of bexmarilimab plus standard-of-care in hig ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results